Oppenheimer Maintains Outperform on HCA Healthcare, Raises Price Target to $345

HCA Holdings, Inc. +1.82% Pre

HCA Holdings, Inc.

HCA

336.16

336.96

+1.82%

+0.24% Pre

Oppenheimer analyst Michael Wiederhorn maintains HCA Healthcare (NYSE: HCA) with a Outperform and raises the price target from $330 to $345.
Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via